Acquisition

After a year of major acquisitions and AI-driven innovation, all eyes are on Labcorp's strategic vision for 2026 at the J.P. Morgan Healthcare Conference.

Treace Medical heads to the J.P. Morgan conference to showcase its surgical tech, facing tough questions on growth amid competition and market shifts.

INVO Fertility realigns its top brass, positioning a deal-making veteran to lead an aggressive clinic acquisition strategy in a booming market.

As 10x Genomics preps for its J.P. Morgan spotlight, investors seek a clear path to profit amid fierce competition and groundbreaking innovation.

Hyatt finalizes a $2B asset sale to Tortuga Resorts, advancing its asset-light strategy while navigating hurricane recovery in the Caribbean.

Fitch Ratings awards NETSTREIT a BBB- rating, a milestone affirming its conservative strategy and unlocking new avenues for growth and capital efficiency.

As Axos sets to reveal its Q2 results, investors weigh strong growth forecasts against mounting concerns over margin pressure and a shifting economy.

KKR's landmark purchase of Cheongna Logistics Center, the largest in Korea, signals a massive bet on the nation's booming e-commerce infrastructure.

New Era Energy & Digital faces a major fraud lawsuit from New Mexico over abandoned oil wells, threatening its pivot to a high-tech data center future.

Berlin-based Sportstech suspends acquisition talks with Nasdaq's TRNR, derailing U.S. plans and sparking a public dispute over the failed deal.

Gaming giant Meridianbet extends its title sponsorship with EuroLeague's Crvena Zvezda, signaling a major strategic play in European basketball.

Analytics giant Crisil launches a new brand platform by Starfish, unifying its global identity to accelerate international growth and redefine trust.

Yodo1’s Transformers: Earth Wars just shifted 57% of its revenue to a webshop, proving a new DTC model is challenging Apple and Google’s dominance.

Peruvian financial giant Credicorp is buying Florida's Helm Bank, a strategic move to capture the lucrative cross-border wealth of Latin American clients.

The biopharma investment giant has now acquired 100% of the royalty stream for Roche's blockbuster SMA drug, a strategic move years in the making.

Influential advisory firm ISS backs Blue Ant's acquisition of Thunderbird, citing a 50% premium and boosting prospects for a Canadian media mega-merger.

Sweetgreen cashes out on its Infinite Kitchen tech, selling to Wonder for $186M. The deal signals a major shift in strategy and the food robotics industry.

Activist investor Saba Capital launches a blistering attack on Edinburgh Worldwide's board, citing governance failures ahead of a crucial shareholder vote.

After a protracted fight against alleged company intimidation, 24 fuel drivers have joined Teamsters Local 705, seeking better wages and benefits.

After a swift restructuring, Modivcare emerges debt-light and privately owned, poised to aggressively invest in technology and transform supportive care.